A new study, for the first time, showed the presence of a specific type of viruses therapy or virotherapy that infect and kill human cancer, making the cells healthy and safe.
The study, conducted by the Mayo Clinic in Minnesota, involving only two patients, both received "a single dose of the measles virus that has been engineered (MV-NIS), which is selectively toxic to myeloma plasma cells," the researchers said.
 |
| Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video. (Picture from: http://bit.ly/1oIYS1G) |
Multiple myeloma affects plasma cells in the bone marrow and cause bone and soft tissue tumors, which very rarely can be cured. This therapy brings complete remission in one patient, although only two patients showed improvement.
"This is the first study to determine the feasibility of viroterapi onkolitic systemically spread to cancer," said Dr. Stephen Russell, a hematologist of Mayo Clinic and lead author of the paper and one of the developers of the therapy.
"These patients previously unresponsive to other therapies and suffered a relapse. Therapy also increases the patient's immune system, and make it able to" sweep "the rest of the cancer," he said.
This therapy may work on other types of cancer. More testing will be done. This discovery appears in the journal Mayo Clinic Proceedings. *** [EKA | FROM VARIOUS SOURCES | VOA NEWS]
Note: This blog can be accessed via your smart phone.
Note: This blog can be accessed via your smart phone.
